Rani Therapeutics Reports Third Quarter 2023 Financial Results, Provides Corporate Update
SAN JOSE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today reported financial results for the quarter ended September…